NCT02955290 2025-11-10
CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer
Roswell Park Cancer Institute
Phase 1/2 Active not recruiting
Roswell Park Cancer Institute
Incyte Corporation
Osaka University